Printer Friendly

ZILA TO MANUFACTURE TOLUIDINE BLUE FOR ORASCAN(TM) IN UNITED STATES

 PHOENIX, Oct. 26 /PRNewswire/ -- Zila Pharmaceuticals, Inc., (a subsidiary of Zila, Inc. (NASDAQ: ZILA)) today reported it has purchased equipment and contracted for the manufacture of the metachromatic stain toluidine blue in the United States, to support worldwide sales of the company's oral cancer diagnostic aid, OraScan(TM).
 Zila President Joseph Hines said the company's dedicated equipment will be used to produce toluidine blue exclusively for OraScan at a U.S. chemical production facility. This will provide Zila with an assured supply of pharmaceutical grade toluidine blue, the critical component of OraScan.
 Hines said the company took this action as a result of discussions held at the U.S. Food and Drug Administration (FDA) on Oct. 21.
 "We are optimistic about gaining marketing approvals in the U.S. and around the world," Hines said. "We intend to be fully prepared to fill OraScan orders in new markets as soon as we have regulatory authorization." OraScan is currently being produced for Zila in Canada and is being sold to dentists and physicians in Canada and Australia.
 -0- 10/26/93
 /CONTACT: Joseph Hines of Zila, 602-266-6700/
 (ZILA)


CO: Zila Pharmaceuticals, Inc.; Zila, Inc. ST: Arizona IN: MTC SU: CON

DT-DC -- DC004 -- 6770 10/26/93 09:30 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 26, 1993
Words:207
Previous Article:WORTHINGTON FOODS' GRILLERS TO BE OFFERED IN ADDITIONAL BURGER KING RESTAURANTS
Next Article:UPJOHN SIGNS LETTER OF INTENT TO SELL ASGROW FLORIDA
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters